跳至主要内容
临床试验/IRCT20120520009801N4
IRCT20120520009801N4招募中2 期

Evaluation of the effect of crocin on prevention of atrial fibrillation after coronary artery bypass grafting (CABG) or valve replacement: a triple-blind, randomized, placebo-controlled trial

Mashhad University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 70 years(—)
性别
All

入选标准

  • Candidates for heart surgery including CABG or valve replacement
  • 70 yr > age > 18 yr
  • Taking ACEIs/ARBs, beta-blockers, statins and aspirin for CABG patients

排除标准

  • Have pacemaker
  • Renal failure (45 = GFR)
  • Hepatic failure (hepatic enzymes > 3 times of upper normal limit )
  • Sensitivity to crocin or saffron
  • History of taking anti-inflammatory or anti-oxidant drugs via two weeks before surgery
  • Thyroid dysfunction
  • Have AF rhythm
  • History of heart surgery
  • Pregnancy and lactation

研究者

相似试验